VJHemOnc is committed to improving our service to you

COMy 2019 | The use of imaging to determine MRD

VJHemOnc is committed to improving our service to you

Elena Zamagni

Elena Zamagni, MD, PhD from the University of Bologna, Bologna, Italy discusses the use of imaging techniques to determine measurable residual disease outside of the bone marrow in patients with multiple myeloma. PET-CT and functional MRI are two techniques currently in use and are being further investigated in clinical trials, as described by Dr Zamagni. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter